Belgian drugmaker UCB and US biotech Biogen have announced positive top-line results from the Phase III PHOENYCS GO study ...

Aptadir Therapeutics, a biotech focused on RNA inhibitor therapies for cancer and genetic conditions, has launched with $1.6 ...

Telix Pharmaceuticals is acquiring US-based RLS Radiopharmacies for $230 million upfront, plus $20 million in performance ...

Shares in San Diego-based inflammatory diseases specialist Ventyx Biosciences (Nasdaq: VTYX) rose 8.7% to $2.50 yesterday as ...

The Association of the British Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) have ...

Two new studies highlight the pharmaceutical sector's crucial role in Greece's economy. The first, The Market in Greece: ...

German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing ...

Shares of California, USA-based precision medicines IDEAYA Biosciences were down 6.3% at $32.5 mid-morning after it revealed ...

Israeli drugmaker Teva Pharmaceuticals presented new research at the European College of Neuropsychopharmacology, including ...

The US Food and Drug Administration (FDA) has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active ...

The Health Sciences Authority (HSA) of Singapore has approved Merck & Co’s Winrevair (sotatercept), for the treatment of ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of Hetronifly ...